TARS
Tarsus Pharmaceuticals, Inc.Company with tickers: TARS
CIK
1819790
CUSIP
87650L103
Shares Outstanding
43,023,959
Website
https://www.tarsusrx.com
13F Activity (30d)
2 filings
1 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
44
Net buyers
-1
Net shares bought
-0.03%
Net buy value
-$877,436
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-17 | Azamian Bobak R. |
Director, President/CEO and Board Chair | Sell | 4,582 |
| 2026-06-17 | Azamian Bobak R. |
Director, President/CEO and Board Chair | Sell | 5,418 |
| 2026-06-16 | Farrow Jeffrey S |
See Remarks | Sell | 14,396 |
| 2026-06-15 | LINK WILLIAM J PHD |
Director | Sell | 10,572 |
| 2026-06-15 | LINK WILLIAM J PHD |
Director | Sell | 1,928 |
| 2026-06-15 | Goodrich Katherine |
Director | Sell | 2,954 |
| 2026-06-15 | Farrow Jeffrey S |
See Remarks | Convert | 27,881 |
| 2026-06-15 | Farrow Jeffrey S |
See Remarks | Convert | 27,881 |
| 2026-06-12 | LINK WILLIAM J PHD |
Director | Convert | 2,954 |
| 2026-06-12 | YARNO WENDY L |
Director | Convert | 2,954 |
| 2026-06-12 | Goodrich Katherine |
Director | Convert | 2,954 |
| 2026-06-12 | Goldberg Andrew D. |
Director | Convert | 2,954 |
| 2026-06-12 | CHAUDHURI BHASKAR |
Director | Convert | 2,954 |
| 2026-06-12 | Morrison Scott W |
Director | Convert | 2,954 |
| 2026-06-12 | CHAUDHURI BHASKAR |
Director | Convert | 2,954 |
| 2026-06-12 | Goodrich Katherine |
Director | Convert | 2,954 |
| 2026-06-12 | Morrison Scott W |
Director | Convert | 2,954 |
| 2026-06-12 | Goldberg Andrew D. |
Director | Convert | 2,954 |
| 2026-06-12 | YARNO WENDY L |
Director | Convert | 2,954 |
| 2026-06-12 | LINK WILLIAM J PHD |
Director | Convert | 2,954 |
| 2026-04-24 | PYOTT DAVID E I |
Director | Convert | 1,383 |
| 2026-04-24 | PYOTT DAVID E I |
Director | Convert | 1,383 |
| 2026-03-20 | Neervannan Seshadri |
Chief Operating Officer | Sell | 2,989 |
| 2026-03-19 | Farrow Jeffrey S |
See Remarks | Sell | 2,186 |
| 2026-03-19 | Whitfield Dianne C. |
Chief Human Resources Officer | Sell | 4,174 |
| 2026-03-19 | Wahl Bryan |
General Counsel | Sell | 4,231 |
| 2026-03-19 | Azamian Bobak R. |
Director, President/CEO and Board Chair | Sell | 11,964 |
| 2026-03-19 | Lin Elizabeth Yeu |
Chief Medical Officer | Sell | 390 |
| 2026-03-19 | Mottiwala Aziz |
Chief Commercial Officer | Sell | 4,440 |
| 2026-03-19 | Neervannan Seshadri |
Chief Operating Officer | Sell | 4,589 |
| 2026-03-18 | Neervannan Seshadri |
Chief Operating Officer | Sell | 3,610 |
| 2026-03-18 | Wahl Bryan |
General Counsel | Sell | 4,125 |
| 2026-03-18 | Whitfield Dianne C. |
Chief Human Resources Officer | Sell | 4,071 |
| 2026-03-18 | Lin Elizabeth Yeu |
Chief Medical Officer | Sell | 379 |
| 2026-03-18 | Farrow Jeffrey S |
See Remarks | Sell | 2,133 |
| 2026-03-18 | Azamian Bobak R. |
Director, President/CEO and Board Chair | Sell | 11,667 |
| 2026-03-18 | Mottiwala Aziz |
Chief Commercial Officer | Sell | 4,330 |
| 2026-03-17 | Whitfield Dianne C. |
Chief Human Resources Officer | Sell | 4,029 |
| 2026-03-17 | Mottiwala Aziz |
Chief Commercial Officer | Sell | 4,286 |
| 2026-03-17 | Neervannan Seshadri |
Chief Operating Officer | Sell | 3,125 |
| 2026-03-17 | Wahl Bryan |
General Counsel | Sell | 4,084 |
| 2026-03-17 | Azamian Bobak R. |
Director, President/CEO and Board Chair | Sell | 10,972 |
| 2026-03-17 | Farrow Jeffrey S |
See Remarks | Sell | 2,111 |
| 2026-03-17 | Lin Elizabeth Yeu |
Chief Medical Officer | Sell | 375 |
| 2026-03-16 | LINK WILLIAM J PHD |
Director | Sell | 8,378 |
| 2026-03-16 | LINK WILLIAM J PHD |
Director | Sell | 493 |
| 2026-03-16 | LINK WILLIAM J PHD |
Director | Sell | 3,629 |
| 2026-03-15 | Neervannan Seshadri |
Chief Operating Officer | Convert | 8,020 |
| 2026-03-15 | Mottiwala Aziz |
Chief Commercial Officer | Convert | 8,148 |
| 2026-03-15 | Azamian Bobak R. |
Director, President/CEO and Board Chair | Convert | 14,878 |
Showing 1–50 of 656 transactions